Book Value per Share: Anew Medical (WENA)

Anew Medical, Inc. (WENA) is developing Klotho protein-based gene therapies to combat ALS and Alzheimer's. The net asset value per share demonstrates the capitalization, with the -0.10 mark characterizing this parameter. Operations are strictly regulated by FDA standards regarding the disposal of biomaterials. The development of new drugs relies on close collaboration with academic research laboratories.

anewmeds.com (WENA) Equity per Share: for the period 06/25/2024 - 09/17/2024

anewmeds.com - analytical breakdowns and key metrics (WENA)

- price and consensus price forecast:
Price Chart Anew Medical, Inc.|WENA - Broker Consensus Forecast
- market capitalization data:
Market Capitalization Anew Medical, Inc.|WENA - Enterprise Value
- book capitalization data:
Net Assets per Single Share Anew Medical|WENA - Accounting Capitalization|Market Capitalization to Book Value Ratio anewmeds.com|WENA - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Anew Medical, Inc.|WENA - Long-Term Debt to Capital|Short-Term Debt to Equity Anew Medical|WENA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Anew Medical, Inc.
Fundamental company valuation:Anew Medical, Inc., WENA

Book value per share reflects the net value of the company's assets minus its liabilities, allowing a book value per share chart to assess the actual tangible support for each security. This metric, calculated as the ratio of equity to the number of shares, confirms the financial stability of Anew Medical, Inc. (WENA) amid the capitalization of intellectual property rights for gene therapy targeting neurodegenerative diseases.

Competitors of Anew Medical, Inc. (WENA)

Biogen Corp (BIIB) - Net Assets per Single Share|NBIX - Equity per Share|RGC: Book Value per Share|AXSM (axsome.com) - Book Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|PRAX (Praxis Precision Medicines) - Book Value per Share|Book Value per Share AVXL|Net Assets per Single Share CeriBell CBLL|Equity per Share Prothena Corporation (PRTA)|ALEC: Book Value per Share|ANNX - Net Asset Value per Share|OMER: Accounting Value per Share|neurogene.com (NGNE) - Accounting Value per Share|Accounting Value per Share AC Immune SA ACIU|VYGR (Voyager Therapeutics Inc) - Accounting Value of a Share|Net Assets per Single Share NMRA|Accounting Value per Share Scilex Holding Company, Inc.|Tevogen Bio Holdings - Book Value per Share|Net Asset Value per Share alphacognition.com (ACOG)|CGTX - Book Value per Share|Equity per Share Inhibikase Therapeutics Inc IKT|Book Value per Share SAVA (Cassava)|ASRT - Net Assets per Share|COYA (coyatherapeutics.com) - Book Value per Share|Vistagen (VTGN) - Accounting Value per Share|OVID (Ovid Therapeutics Inc) - Book Value per Share|Book Value per Share ABOS|Net Assets per Single Share CervoMed Inc (CRVO)|Net Assets per Single Share alteritytherapeutics.com ATHE|Accounting Value per Share Clene|Accounting Value of a Share PepGen Inc PEPG|Book Value per Share JUNS (Jupiter Neurosciences Inc)|RLMD: Net Assets per Share|Net Assets per Single Share Annovis Bio Corp|Grace Therapeutics (GRCE) - Equity per Share|Book Value per Share AIFF|Accounting Value per Share ANEW Medical, Inc. (KLTO)|NRSN (NeuroSense Therapeutics) - Accounting Value per Share|Net Assets per Share Reviva Pharmaceuticals Holdings Inc. RVPH|MetaVia - Accounting Value per Share|Accounting Value per Share NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Book Value per Share|PASG: Net Asset Value per Share|Net Assets per Single Share bionomics.com.au|Minerva Neurosciences Inc (NERV) - Equity per Share|ATHA (Athira) - Book Value per Share|Book Value per Share ADXN|Net Assets per Single Share Alzamend Neuro, Inc. ALZN|Equity per Share cyclerion.com (CYCN)|PTIX: Book Value per Share|KTTA - Net Asset Value per Share|Cortigent Medical - Accounting Value per Share|ATXI: Book Value per Share|Net Assets per Single Share Brainstorm Cell BCLI|CARA (caratherapeutics.com) - Accounting Value of a Share|Net Assets per Single Share CHRO (Chromocell Therapeutics Corp.)|Net Asset Value per Share Eliem|Book Value per Share ITCI|Book Value per Share LBPH (Longboard)|MRNS - Net Assets per Single Share|Equity per Share nkgenbiotech.com NKGN|NRBO (NeuroBo Pharmaceuticals, Inc.) - Book Value per Share|Sage Therapeutics Inc. (SAGE) - Net Asset Value per Share|SNPX (Neurotrope) - Accounting Value per Share|Accounting Value per Share Trevena Inc|VIGL - Accounting Value per Share|Accounting Value of a Share CERE